Dr. Sarah Hodge and the Division of Otology and Neurotology were chosen as a site for a Cochlear Implant Center of Excellence pilot study by Cochlear of Americas. Only 3 sites across the US were chosen and this honor comes with a sizeable grant. The primary goal of the study is to evaluate the division’s CI program from a systems standpoint and identify areas where access to initial CI evaluation, CI surgery, and post-op activation may be inefficient and contribute to delays in care.
The first part of the study is retrospective looking at the last 5 years of CI surgery at MCG-AU to identify areas of system breakdown. The next part is a prospective study evaluating how the implemented changes ultimately streamline hearing restoration. This esteemed grant and collaboration elevate MCG-AU to national prominence, and we're thrilled about the potential impact on both our program and our patients.
Dr. J. Kenneth Byrd is a co-investigator on a recent RO1 grant award of over $3.99 million from the National Institute of Dental and Craniofacial Research (NIDCR). This collaborative research project seeks to deepen our understanding of the CD73-A2BR pathway in the head and neck cancer (HNSC) microenvironment that regulates the immune landscape in murine models and patient specimens. The overarching goal is to develop CD73-A2BR immune checkpoint blockade regimens for more effective HNSC treatment.
Coulter M, Greene H, Miller T, Brady R, Bennett C, Johnson C. The Quality of Otolaryngology- Head and Neck Surgery Literature over the Last Decade. Laryngoscope. 2023 Aug;133(8):1853-1856. doi: 10.1002/lary.30446. PMID: 36250586.
Teng SE, Booth JR, Fritz MA, Groves MW, Postma GN. Airway Management in Singers: A Cross-sectional Survey. J Voice. 2023 Sep;37(5):772-778. doi: 10.1016/j.jvoice.2021.04.012. PMID: 34120797.
Newman S, Cowart JH, Omar N, Martin E, Byrd JK. HPV-associated oropharyngeal Adenosquamous carcinoma with early metastatic disease detected by ctDNA. Oral Oncol. 2023 Oct;145:106526. doi: 10.1016/j.oraloncology.2023.106526. Epub 2023 Jul 21. PMID: 37482044.
Kurago Z, Guo G, Shi H, Bollag RJ, Groves MW, Byrd JK, Cui Y. Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy. Front Immunol. 2023 Jun 26;14:1212209. doi: 10.3389/fimmu.2023.1212209. PMID: 37435071; PMCID: PMC10330720.
Nijim W, Cowart JH, Banerjee C, Postma G, Paré M. Evaluation of outcome measures for post-operative dysphagia after anterior cervical discectomy and fusion. Eur Arch Otorhinolaryngol. 2023 Aug 17. doi: 10.1007/s00405-023-08167-7. Epub ahead of print. PMID: 37592082.